uniQure NV (QURE)
5.02
-0.05
(-0.99%)
USD |
NASDAQ |
May 17, 16:00
5.02
0.00 (0.00%)
After-Hours: 20:00
uniQure Free Cash Flow (Quarterly): -62.92M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -62.92M |
December 31, 2023 | -51.58M |
September 30, 2023 | 37.21M |
June 30, 2023 | -58.07M |
March 31, 2023 | -80.64M |
December 31, 2022 | -59.75M |
September 30, 2022 | -52.98M |
June 30, 2022 | -20.26M |
March 31, 2022 | -29.77M |
December 31, 2021 | -50.64M |
September 30, 2021 | -47.85M |
June 30, 2021 | 414.16M |
March 31, 2021 | -45.15M |
December 31, 2020 | -39.87M |
September 30, 2020 | -36.89M |
June 30, 2020 | -31.71M |
March 31, 2020 | -35.84M |
December 31, 2019 | -27.97M |
September 30, 2019 | -24.28M |
June 30, 2019 | -25.42M |
March 31, 2019 | -27.67M |
December 31, 2018 | -18.74M |
September 30, 2018 | -20.92M |
Date | Value |
---|---|
June 30, 2018 | -18.53M |
March 31, 2018 | -22.09M |
December 31, 2017 | -19.26M |
September 30, 2017 | -16.38M |
June 30, 2017 | -20.57M |
March 31, 2017 | -13.64M |
December 31, 2016 | -19.92M |
September 30, 2016 | -27.42M |
June 30, 2016 | -24.43M |
March 31, 2016 | -17.59M |
December 31, 2015 | -25.65M |
September 30, 2015 | -1.922M |
June 30, 2015 | 42.27M |
March 31, 2015 | -15.25M |
December 31, 2014 | -18.22M |
September 30, 2014 | -12.60M |
June 30, 2014 | -17.19M |
March 31, 2014 | -11.34M |
December 31, 2013 | -10.60M |
September 30, 2013 | 10.10M |
June 30, 2013 | -8.387M |
March 31, 2013 | -5.098M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-80.64M
Minimum
Mar 2023
414.16M
Maximum
Jun 2021
-16.51M
Average
-38.38M
Median
Free Cash Flow (Quarterly) Benchmarks
ProQR Therapeutics NV | -17.23M |
Merus NV | -44.45M |
argenx SE | -- |
Pharming Group | -7.727M |
Pharvaris NV | -26.35M |